Full Text
Cost Effectiveness of Different Targeted Treatment Sequences for HER2-Positive Metastatic Breast Cancer

Abstract

Authors

V Diaby G Adunlin A Ali S Zeichner G Lopes CG Kohn AJ Montero

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×